# Exploring the Cutting Edge: A Recap of EULAR & ACR 2023 Highlights for Spondyloarthritis, including Psoriatic Arthritis

## TL;DR

This article summarizes key research and developments in spondyloarthritis and psoriatic arthritis from two major rheumatology conferences in 2023.

## Contribution

It provides a focused overview of recent advancements and insights presented at EULAR and ACR 2023.

## Key findings

- The conferences highlighted the challenges in diagnosing inflammatory spondyloarthritis due to its diverse clinical features.
- New research and treatment strategies for managing these rheumatic conditions were discussed.
- The article emphasizes the importance of these meetings in advancing rheumatology knowledge.

## Abstract

As the field of rheumatology continues to advance, the European Alliance of Associations for Rheumatology (EULAR) and the American College of Rheumatology (ACR) annual meetings stand as pivotal events, showcasing the latest research, treatments, and insights into various rheumatic diseases. Among these, Inflammatory Spondyloarthritis presents a unique challenge, characterised by its elusive diagnostic markers and diverse clinical manifestations. In this article, we delve into the highlights and findings from EULAR 2023 and ACR 2023, shedding light on the latest advancements in understanding and managing these complex rheumatic conditions.